Answers are grounded in this paper and cite their sources.
This work demonstrates an innovative patch for diagnosing and treating UV-induced skin cancer, suggesting personalized care at home.
Early stage skin cancer exhibits a high cure rate; however, conventional noninvasive screening suffers from diagnostic inaccuracies, and treatment reliant on postlesion surgery remains inherently passivity. This work develops an all-in-one platform by coupling microneedle (MN) patches with a lateral flow immunoassay (LFIA), seamlessly integrating self-powered biomarker extraction, multimodal detection, and biomarker-responsive therapy for point-of-care testing (POCT) and personalized treatment of UV-induced early stage skin cancer. It incorporates a thermogalvanic cell (TGC) MN, which leverages photothermal-thermoelectric coupling to achieve external power-free transdermal extraction of the biomarker (8-OH-dG) within 10 min. The extracted 8-OH-dG triggers the structural change of the hairpin aptamer (HA) on the PtPB@PEG@HA (PPPA) nanoparticles (NPs), initiating a cascade amplification that generates abundant DNA nanozymes for colorimetric detection (100 pM to 60 nM). A convolutional neural network (CNN) is introduced for colorimetric quantification, coupled with artificial intelligence (AI) for disease risk assessment. Once captured in the LFIA detection zone by a capture probe, the open-loop PPPA NPs permit surface-enhanced Raman spectroscopy (SERS) detection of 8-OH-dG, enabling dual-mechanism cross-verification. Under near-infrared (NIR) irradiation, the PPPA NPs also serve as photothermal actuators to trigger the controlled release of quercetin from phase-transition MNs, effectively scavenging UV-induced oxidative stress. This innovation facilitates the home-based diagnosis and management of early stage skin cancer.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: